Asia watches Althea’s equipment in action

Althea were delighted to support Leicester’s Hospitals’ cardiologists and cardiac surgeons perform a live Transcatheter Aortic Valve Implantation (TAVI) procedure to colleagues across Asia.

The procedure, which was carried out using an array of Althea’s CT, MRI and ultrasound scanners, was transmitted live from the cardiac catheter lab at Glenfield Hospital. It was watched by 21,295 international health professionals from 36 countries as part of the 29th Great Wall International Congress of Cardiology and Asia Pacific Structural Symposium and China Structure Week.

Thanks to the internet, IT and the team working earlier than usual the procedure was performed live from 5am UK time. It was the first time a transmission was purely delivered online. Previously, satellite has been relied upon which is not as seamless.

The world-recognised TAVI procedure allows heart valves to be implanted using a catheter. The procedure is minimally invasive and means patients, particularly the elderly, do not have to undergo open-heart surgery.

Before the procedure the patient requires either a CT scan or an ultrasound to confirm the size of the aortic root and the degree of classification and competency of the valve.

Althea also procured the correct size of valve required for the procedure, specific to the patient’s anatomical specification.

Ruben Olivier explains: “Althea procured the item via the bespoke althea P2P product catalogue system and the supplied it in time for the scheduled procedure. We were also on hand to collect the item from the hospital delivery point to check when it arrived at the hospital to confirm it had arrived undamaged.”

“As part of our role we recorded the serial number and the device is tracked and traced within the Althea inventory management system. Once the valve is implanted, it is scanned with our point of care scanners and recorded against the patient ID number. This follows the NHS recommended Scan4Safety protocol.This allows for tracking the valve in the event of a MHRA recall or field safety notification.”

After the implant, the patient will undergo a secondary scan to assess the position of the valve to confirm the successful outcome of the procedure.

Althea have a monthly clinical governance meeting where the implanted items are monitored, and the continuous safety and quality of the implant is recorded.